SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-024672
Filing Date
2020-04-16
Accepted
2020-04-16 17:33:21
Documents
1
Period of Report
2020-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6273
  Complete submission text file 0001209191-20-024672.txt   7679
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY SAN FRANCISCO CA 94083
Business Address
SCANGOS GEORGE A (Reporting) CIK: 0001202102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 20797241

Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences